We seem to discuss rights offerings ad nauseam. However, we haven't really touched on the basics of a tender offer. Instead of the disruptive nature that we see with rights offering and causing ...
LARKSPUR, Calif.--(BUSINESS WIRE)--As previously announced, on July 16, 2023, MediPacific Sub, Inc. (“Purchaser”) and MediPacific, Inc. (“Parent”), affiliates of Foresite Capital, entered into a ...
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (XOMA) entered into a merger agreement to acquire Kinnate Biopharma Inc. (KNTE) ...
SAN DIEGO--(BUSINESS WIRE)-- As previously announced on December 22, 2023, Concentra Biosciences, LLC (“Parent”) and its wholly owned subsidiary, Concentra Merger Sub II, Inc. (“Purchaser”), entered ...
Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolio EMERYVILLE, Calif., March 19, ...